SS Innovations International Inc. (NASDAQ: SSII) is emerging as a key player in the surgical robotics space, driven by its innovative SSi Mantra system. The company’s technology offers clinically validated, cost-effective solutions with unique capabilities in cardiac surgery, pediatric procedures, and telesurgery. These attributes, combined with a large addressable market and strong industry tailwinds, make SSII a company to watch.
The SSi Mantra system, developed by a team led by Dr. Sudhir Srivastava, an acclaimed robotic cardiac surgeon and the company’s founder, Chairman and CEO, features modularity, user friendliness, and relative cost advantages. Its commercial success since late 2022 has been fueled by these differentiators, resulting in rapid revenue growth. The company is headquartered in India but is expanding globally, with a focus on democratizing access to advanced surgical robotics.
SS Innovations has a stronghold in India and is pursuing global expansion, with potential catalysts in the US and EU markets. The company benefits from world-class R&D and manufacturing facilities, robust sales growth, expanding margins, and an increasing mix of recurring revenue. An aligned and accomplished management team and Board of Directors further support its growth trajectory.
Investors can find the latest news and updates relating to SSII in the company’s newsroom at https://ibn.fm/SSII. This press release is distributed by InvestorWire, a specialized communications platform within the Dynamic Brand Portfolio @IBN. InvestorWire provides access to a vast network of wire solutions, article and editorial syndication to 5,000+ outlets, enhanced press release distribution, social media distribution, and tailored corporate communications solutions. For more information, visit https://www.InvestorWire.com.
Please see full terms of use and disclaimers on the InvestorWire website applicable to all content provided by IW, wherever published or re-published: https://www.InvestorWire.com/Disclaimer.
